DOVA earnings call for the period ending June 30, 2019.
News & Analysis: Dova Pharmaceuticals, Inc.
It was a great week for these three stocks, but can they continue climbing?
The drugmaker's Doptelet therapy just received an expanded approval.
DOVA earnings call for the period ending March 31, 2019.
DOVA earnings call for the period ending December 31, 2018.
A tough market and bad news sent these stocks sharply lower.
Traders flee in response to a surprise management shake-up and weak financial guidance.
Hot on the heels of its IPO, this company hopes to soon file for FDA approval of a new drug targeting a billion-dollar indication.